Literature DB >> 11804793

RanBP1, a velocardiofacial/DiGeorge syndrome candidate gene, is expressed at sites of mesenchymal/epithelial induction.

Thomas M Maynard1, Gloria T Haskell, Naina Bhasin, James M Lee, Andrew A Gassman, Jeffrey A Lieberman, Anthony-Samuel LaMantia.   

Abstract

RanBP1, a velocardiofacial syndrome/DiGeorge syndrome candidate gene, is expressed in the frontonasal processes, branchial arches, aortic arches, and limb buds. At these sites, RanBP1 apparently coincides with neural crest-derived mesenchymal cells. In addition, RanBP1 is expressed in the forebrain as well as in hindbrain regions previously associated with crest-derived mesenchymal cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804793     DOI: 10.1016/s0925-4773(01)00616-5

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  12 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  No evidence for parental imprinting of mouse 22q11 gene orthologs.

Authors:  Thomas M Maynard; Daniel W Meechan; Clifford C Heindel; Amanda Z Peters; Robert M Hamer; Jeffrey A Lieberman; Anthony-Samuel LaMantia
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

3.  Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation.

Authors:  Elizabeth M Paronett; Daniel W Meechan; Beverly A Karpinski; Anthony-Samuel LaMantia; Thomas M Maynard
Journal:  Cereb Cortex       Date:  2014-12-01       Impact factor: 5.357

Review 4.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

Review 5.  Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes.

Authors:  D W Meechan; T M Maynard; E S Tucker; A-S LaMantia
Journal:  Int J Dev Neurosci       Date:  2010-09-15       Impact factor: 2.457

Review 6.  When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.

Authors:  D W Meechan; T M Maynard; D Gopalakrishna; Y Wu; A S LaMantia
Journal:  Gene Expr       Date:  2007

7.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain.

Authors:  T M Maynard; G T Haskell; A Z Peters; L Sikich; J A Lieberman; A-S LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

Review 8.  Hard to swallow: Developmental biological insights into pediatric dysphagia.

Authors:  Anthony-Samuel LaMantia; Sally A Moody; Thomas M Maynard; Beverly A Karpinski; Irene E Zohn; David Mendelowitz; Norman H Lee; Anastas Popratiloff
Journal:  Dev Biol       Date:  2015-11-07       Impact factor: 3.582

9.  Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome.

Authors:  Beverly A Karpinski; Thomas M Maynard; Matthew S Fralish; Samer Nuwayhid; Irene E Zohn; Sally A Moody; Anthony-S LaMantia
Journal:  Dis Model Mech       Date:  2013-12-19       Impact factor: 5.758

Review 10.  In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects?

Authors:  Zahra Motahari; Sally Ann Moody; Thomas Michael Maynard; Anthony-Samuel LaMantia
Journal:  J Neurodev Disord       Date:  2019-06-07       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.